Patent · US Active

Methods of producing antigen-specific B cell populations in the presence of CD40:CD40L, BAFF:BAFF receptor and Fas:FasL stimulation

US8815543B2 · kind B2 · utility

2Cited by
1References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 25, 2010
Grant dateAug 26, 2014
Priority date
Expiry dateOct 25, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2501/52
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention provides a method for producing an antigen-specific B cell population comprising IgG-positive B cells specific to a specific antigen, the method comprising: culturing IgG-positive B cells together with the specific antigen in the presence of IL-21, while conferring stimulation to the IgG-positive B cells via CD40, a BAFF receptor and Fas; and screening for antigen-specific B cells specific to the specific antigen to obtain an antigen-specific B cell population comprising the IgG-positive B cells specific to the specific antigen.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.